Management Team

Dr. Christoph Ganss

Physician, CEO and founder

Dr. med. Christoph Ganss, dedicated doctor and entrepreneur, has many years’ experience in surgical techniques. He acquired in-depth knowledge and state-of-the-art medical and scientific skills both at home and abroad.

Born into a family of business owners, Dr. Ganss was fascinated by the interplay between science and business from the outset. In 2003, he set up RHEACELL's parent company, TICEBA - the world's first tissue bank for skin stem cells and now a leading biopharmaceutical company - at the Heidelberg Technology Park.

I am fascinated by what we and the entire RHEACELL team (TICEBA subsidiary) have achieved together in such a short space of time: from in-depth research through to clinical trials focusing on drug development.
Dr. Christoph Ganss
Physician, CEO and founder

Dr. Christoph Ganss

Physician, CEO and founder

Dr. Andreas Kluth


Fabian Immink


Andreas Sticher

Head of Sourcing & Purchasing

Prof. Markus Frank, MD

Associate Professor of Pediatrics and Dermatology; Harvard Medical School; Co-Leader, Harvard Stem Cell Institute Skin Program

Prof. John McGrath

Academic Head of Department, St John's Institute of Dermatology; Mary Dunhill Chair in Cutaneous Medicine

Prof. Karin Scharffetter-Kochanek, MD, PhD

Medical Director, Department for Dermatology and Allergic Diseases, Ulm University Medical Center

Dr. Seda Ballikaya

Head of Manufacturing (TICEBA)

Kathrin Dieter

Head of Clinical Operations (RHEACELL)

Dr. Jasmina Esterlechner

Head of Quality Assurance (TICEBA)

Dr. Silvia Fluhr

Drug Supply (RHEACELL)

Samar Sadeghi

Head of Quality Control (TICEBA)

Dr. Hannes Schröder

Pharmacovigilance (RHEACELL)

© 2021 RHEACELL. All rights reserved.